| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder. | Can J Clin Pharmacol | 2006 | 2.08 |
| 2 | Do formulation switches exacerbate existing medical illness? Results of an open-label transition to orally disintegrating risperidone tablets. | Hum Psychopharmacol | 2007 | 0.79 |